Literature DB >> 8573743

Advanced glycation endproducts and diabetic nephropathy.

Z Makita1, K Yanagisawa, S Kuwajima, N Yoshioka, T Atsumi, Y Hasunuma, T Koike.   

Abstract

Diabetic nephropathy is currently the single largest cause of endstage renal disease (ESRD) in the United States and many European countries. The primary cause for the development of diabetic complications (including diabetic nephropathy) is persistent exposure to hyperglycemia, although genetic and other incompletely understood factors also play an important role. Although much consideration has been given to the pathogenesis and genetics of the disease itself, the mechanisms by which persistent exposure to hyperglycemia cause biochemical and metabolic alterations have been very sketchily understood. Recently, a growing body of evidence has linked the accumulation of the late products of glucose-protein interaction to a variety of chronic complications, including diabetic nephropathy. The formation of irreversible advanced glycosylation endproducts (AGEs) resulting from the spontaneous reaction between glucose and proteins occur most noticeably on long-lived structural proteins. Recent studies demonstrate that the pathogenesis of diabetic nephropathy is caused by the hyperglycemia-accelerated formation of AGEs. Also, reactive AGE peptides in the circulation are thought to play a role as a new version of so called middle molecule toxic substances. This evidence is opening a new window for our understanding of the pathogenesis of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8573743     DOI: 10.1016/1056-8727(95)80018-a

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  9 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

Review 2.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

3.  In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Authors:  Angela Cassese; Iolanda Esposito; Francesca Fiory; Alessia P M Barbagallo; Flora Paturzo; Paola Mirra; Luca Ulianich; Ferdinando Giacco; Claudia Iadicicco; Angela Lombardi; Francesco Oriente; Emmanuel Van Obberghen; Francesco Beguinot; Pietro Formisano; Claudia Miele
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

4.  Amino-guanidinium hydrogen fumarate.

Authors:  Swaminathan Murugavel; Gnanavelu Ganesh; Arunachalathevar Subbiah Pandi; Subbiah Govindarajan; Rajendran Selvakumar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-02-18

5.  Amino-guanidinium hydrogen succinate.

Authors:  S Murugavel; P S Kannan; A Subbiah Pandi; S Govindarajan; R Selvakumar
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-02-04

Review 6.  Modulation of insulin action.

Authors:  L Pirola; A M Johnston; E Van Obberghen
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

7.  Study of an unusual advanced glycation end-product (AGE) derived from glyoxal using mass spectrometry.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Isolda Romero Canelon; Mark P Barrow; David Kilgour; Naila Rabbani; Paul J Thornalley; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-28       Impact factor: 3.109

8.  Hyperglycaemia inhibits REG3A expression to exacerbate TLR3-mediated skin inflammation in diabetes.

Authors:  Yelin Wu; Yanchun Quan; Yuanqi Liu; Keiwei Liu; Hongquan Li; Ziwei Jiang; Tian Zhang; Hu Lei; Katherine A Radek; Dongqing Li; Zhenhua Wang; Jilong Lu; Wang Wang; Shizhao Ji; Zhaofan Xia; Yuping Lai
Journal:  Nat Commun       Date:  2016-11-10       Impact factor: 14.919

9.  Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.

Authors:  Robert P van Waateringe; Sandra N Slagter; Melanie M van der Klauw; Jana V van Vliet-Ostaptchouk; Reindert Graaff; Andrew D Paterson; Helen L Lutgers; Bruce H R Wolffenbuttel
Journal:  Eur J Clin Invest       Date:  2016-04-15       Impact factor: 4.686

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.